Sejong Medical Co., Ltd. (258830) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sejong Medical Co., Ltd. (258830:KRX), powered by AI.

Current Price
₩412
P/E Ratio
-1227.0
Market Cap
31.2B
Sector
Healthcare
What is the Sejong Medical Co., Ltd. stock price forecast?

Sejong Medical Co., Ltd. is currently trading at ₩412. View real-time AI analysis on Alpha Lenz.

What is Sejong Medical Co., Ltd. insider trading activity?

View the latest insider trading data for Sejong Medical Co., Ltd. on Alpha Lenz.

What is Sejong Medical Co., Ltd.'s P/E ratio?

Sejong Medical Co., Ltd.'s P/E ratio is -1227.0.

Sejong Medical Co., Ltd.

KRX · 258830
₩412+0(+0.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Sejong Medical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sejong Medical Co., Ltd. trades at a P/E of -1227.0 (undervalued) with modest ROE of -0.1%.

Ask for details

Company Overview

Sejong Medical Co., Ltd. is a medical technology company dedicated to the development, manufacturing, and distribution of innovative healthcare solutions. The company's primary focus lies in the production of medical devices that enhance surgical procedures and patient outcomes, particularly in the fields of minimally invasive surgery and oncology. Notable for its robust research and development capabilities, Sejong Medical Co., Ltd. is committed to advancing medical technology to meet the evolving needs of healthcare professionals and patients alike. Operating across various medical sectors, Sejong Medical’s products cater to an extensive range of healthcare facilities, including hospitals and surgical centers. By prioritizing quality and safety standards, the company ensures that its devices are both effective and reliable, cementing its position in the competitive medical device industry. In the financial market, Sejong Medical Co., Ltd. is recognized for its contribution to the healthcare sector, offering investors exposure to the growing demand for advanced medical technology and solutions. Its innovations have significant implications for improving surgical precision and patient care, highlighting its importance within the broader healthcare landscape.

CEO강동주
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees130

Company Statistics

FY 2025

Profile

₩31,223,976,612Market Cap
₩18,535,097,960Revenue
75.79MShares Out
130Employees

Margins

55.76%Gross
20.36%EBITDA
12.38%Operating
-0.09%Pre-Tax
-0.14%Net

Valuation

-1226.99P/E
1.38P/B
1.68EV/Sales
14.06EV/EBITDA
-4.99P/FCF

Growth (CAGR)

4.84%Rev 3Yr
4.19%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.05%ROA
-0.12%ROE
2.31%ROIC

Financial Health

₩7,040,014,970Cash & Cash Equivalents
₩30,129,183,160Net Debt
164.20%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sejong Medical Co., Ltd. (ticker: 258830) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 130 employees. Market cap is $31.2B.

The current price is ₩412 with a P/E ratio of -1,226.99x and P/B of 1.38x.

ROE is -0.12% and operating margin is 12.38%. Annual revenue is $18.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sejong Medical Co., Ltd. (258830) Stock Forecast 2026 ₩412 — Price, Financials & Analyst Targets | Alpha Lenz